The potential global market size and public health value of an HIV-1 vaccine in a complex global market (Q30389175)

21 June 2017

title

The potential global market size and public health value of an HIV-1 vaccine in a complex global market (English)

1 reference

21 June 2017

0 references

0 references

5

Nina Russell

1 reference

21 June 2017

Carol A Marzetta

1

1 reference

21 June 2017

Stephen S Lee

2

1 reference

21 June 2017

Sandra J Wrobel

3

1 reference

21 June 2017

Kanwarjit J Singh

4

1 reference

21 June 2017

José Esparza

6

1 reference

21 June 2017

language of work or name

English

0 references

publication date

14 May 2010

1 reference

21 June 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

volume

28

1 reference

21 June 2017

issue

30

1 reference

21 June 2017

page(s)

4786-4797

1 reference

HIV Vaccines: A Global Perspective

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

HIV vaccine trial results--an opening for further research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Estimating the number of men who have sex with men in low and middle income countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Men who have sex with men and HIV/AIDS in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

The global epidemic of HIV infection among men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Sex in Australia: sexual identity, sexual attraction and sexual experience among a representative sample of adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Estimates of the number of female sex workers in different regions of the world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

HIV in prison in low-income and middle-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Preventing needlestick injuries among healthcare workers: a WHO-ICN collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

The national security implications of HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Neutralizing inter-clade cross-reactivity of HIV-1 V1/V2-specific secretory immunoglobulin A in Colombian and French cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Estimation of ?needs? and ?probable uptake? for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

Demand forecasting for preventive AIDS vaccines: economic and policy dimensions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

The impact of an AIDS vaccine in developing countries: a new model and initial results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.04.098

10.1016/J.VACCINE.2010.04.098

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference